
Risk factors affecting DED severity
According to the large Dry Eye Assessment and Management (DREAM) study, patients with facial rosacea and peripheral artery disease experience more severe dry eye disease symptoms.

According to the large Dry Eye Assessment and Management (DREAM) study, patients with facial rosacea and peripheral artery disease experience more severe dry eye disease symptoms.

Dry eye disease (DED) is one of the most common yet undertreated ocular surface conditions. The Tear Film and Ocular Surface Society’s second Dry Eye Workshop (TFOS DEWS II) recognised DED as a multifactorial, self-perpetuating vicious circle characterised by tear film instability and hyperosmolarit

Prominent Japanese eye health groups are urging caution over the use of blue-light-blocking glasses for children, arguing that a lack of exposure to sunlight increases the risk

A review of AMD data has led researchers to propose that it should be considered a disease spectrum due to its differing mechanisms and underlying causes. Co-authored by Melbourne’s Professor

Australian startup Speckles, which produces fun patches for children with amblyopia, has launched a campaign to make the language around the condition more positive and reduce the stigma of

In an online survey of cataract surgeons and nurses, 93% agreed that operating room (OR) waste is excessive, with 78% in favour of reusing OR supplies. Of the 1,300 surveyed, 90% agreed that profit,

A coalition that includes the International Agency for Prevention of Blindness (IAPB) and Bayer is launching a multi-country patient and clinician survey to evaluate the delivery of care for

Auckland University researchers have conducted a pilot eye health survey and community eye exams in east-central Auckland, uncovering significant unmet need and serious eye disorders, including retinal tears and severe cataracts.

New Zealand’s ophthalmic nurses are being encouraged to ‘get a seat at the table’ by being part of the new International Ophthalmic Nursing Association (IONA).

The Centre for Eye Research Australia has found that long-term use of the statin rosuvastatin was associated with a higher risk of glaucoma onset.

Allegro Ophthalmics, a privately held US biopharmaceutical company, has announced that all primary and secondary endpoints of a 64-eye vehicle-controlled study of ALG-1007 topical eye drop in patients with dry eye disease (DED) were met.

Kiwi optometrists are being invited to participate in a nationwide year-long prospective study on suspicious pigmented eye lesions.
